Sep 24 2009
Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that Palmetto GBA and TrailBlazer Health Enterprises, LLC -- two large regional Medicare carriers serving over 10.2 million beneficiaries in California, Nevada, Hawaii, Texas, Oklahoma, Colorado, New Mexico and Virginia -- have agreed to cover the Renessa(R) treatment for female SUI (stress urinary incontinence) in appropriately selected patients with documented medical necessity.
Palmetto's website states, "Effective September 1, 2009, Palmetto GBA will cover the Renessa procedure ... in women who have failed conservative treatment but do not wish or are not candidates for surgical procedures and do not have structural abnormalities that would contraindicate the procedure." Palmetto limits coverage to once per lifetime and requires that physicians performing the Renessa procedure have proof of adequate training. http://www.palmettogba.com/palmetto/Providers.nsf/vMasterDID/7VHNVN3810?opendocument
TrailBlazer states on its website that effective July 1, 2009, Renessa was removed from the section titled "Investigational, Unproven or Experimental.">
"We are very pleased with these new coverage decisions for Renessa," said Debra Reisenthel, Novasys Medical President and Chief Executive Officer. "Progressive Medicare Medical Directors covering twenty-one states have made Renessa available to women with a documented history of SUI. Many women are not candidates for invasive surgery or want to avoid it. This gives them an option that is more effective than previously available conservative therapies."
Palmetto and TrailBlazer join Medicare carriers Noridian, First Coast, Highmark and Pinnacle, and national private payer Aetna US Healthcare, in covering this safe and effective non-surgical treatment for women who suffer from the debilitating effects of SUI. In addition, Blue Cross Blue Shield of Florida recently announced coverage for Renessa for its Medicare Advantage Plan members. It is anticipated that many more Medicare Advantage plans will be extending coverage to their beneficiaries in the areas where Medicare carriers are covering this safe and effective non-surgical SUI treatment.